Cotec Healthcare IPO is a Book Building listing on BSE,NSE exchange, with an ipo size of ₹ [●] Cr. The company is based in Roorkee and caters to Pharmaceutical sector. Pantomath Capital Advisors is the merchant banker of Cotec Healthcare IPO. It is a MainBoard Upcoming IPO which filed its Draft Red Herring Prospectus (DRHP) on 10th September 2025.
Cotec Healthcare IPO posted revenues of ₹ 192.24 Cr. and PAT of ₹ 20.00 Cr. in FY25 on annualised basis.Financial results of Cotec Healthcare IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
Financials | FY25 | FY24 | FY23 | ||
---|---|---|---|---|---|
Balance Sheet
|
|||||
Assets | 136.63 | 95.83 | 68.65 | ||
Net Worth | 58.97 | 38.90 | 28.34 | ||
Total Debt | 26.07 | 15.48 | 11.24 | ||
Profit & Loss
|
|||||
Revenue
Revenue on annualised basis |
192.24 | 138.00 | 82.42 | ||
EBITDA
EBITDA on annualised basis |
31.44 | 17.12 | 9.51 | ||
PAT
PAT on annualised basis |
20.00 | 10.56 | 5.07 |
Cotec Healthcare IPO PAT Margin is 10.40 % , ROCE (Return on Capital Employed) is 36.43 % as per latest financial. The below table shows Cotec Healthcare IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
Particulars | FY25 | FY24 | FY23 |
---|---|---|---|
EBITDA Margin (%) | 16.35 | 12.41 | 11.54 |
PAT Margin (%) | 10.40 | 7.65 | 6.15 |
EPS (₹) | 1.75 | 0.92 | 0.44 |
ROE (%) | 33.92 | 27.15 | 17.89 |
ROCE (%) | 36.43 | 33.31 | 21.49 |
ROA (%) | 14.64 | 11.02 | 7.39 |
Debt to Equity | 0.44 | 0.40 | 0.40 |
The market Capitalisation of Cotec Healthcare IPO is ₹ [●] crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Cotec Healthcare IPO prospectus highlights an Return on Equity (ROE) of 33.92 % , Return on Assets (ROA) of 14.64 %, and an EBITDA Margin of 16.35 %, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Cotec Healthcare IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Cotec Healthcare IPO is ₹ [●] Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Cotec Healthcare IPO has a Price-to-Earnings (PE) ratio of [●], indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Cotec Healthcare IPO reported revenue of ₹ 192.24 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Cotec Healthcare IPO provide insights into sales growth, market demand, and business scalability.
Cotec Healthcare recorded an EBITDA of ₹ 31.44 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Cotec Healthcare Profit After Tax (PAT) is ₹ 20.00 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Cotec Healthcare operates in Pharmaceutical and Contract Development And Manufacturing Organization (CDMO) Of Drugs. The Issue is listed on BSE,NSE in Oct, 2025. Cotec Healthcare IPO size was with Issue price of .
Merchant Banker(s) of Cotec Healthcare IPO: Pantomath Capital Advisors Private Limited
Cotec Healthcare IPO subscription was X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Cotec Healthcare IPO listed at a listing price of against the offer price of .
The current market price of Cotec Healthcare is .
Why Us?